簡易檢索 / 詳目顯示

研究生: 陳尚源
Chen, Shang-Yuan
論文名稱: 具多重響應性與螢光共振能量轉移之高分子混合微胞於藥物釋放以及監測藥物釋放之應用
The Application of Polymeric Mixed Micelle with Multiple Stimuli-Responsive and Förster Resonance Energy Transfer in Drug Release and Monitoring
指導教授: 吳文中
Wu, Wen-Chung
學位類別: 碩士
Master
系所名稱: 工學院 - 化學工程學系
Department of Chemical Engineering
論文出版年: 2024
畢業學年度: 112
語文別: 中文
論文頁數: 109
中文關鍵詞: 雙親性嵌段高分子 、溫度響應性 、酸鹼響應性 、氧化還原響應性 、聚集誘導螢光 、螢光共振能量轉移 、藥物釋放
外文關鍵詞: amphiphilic block copolymer, thermo-responsive, pH-responsive, redox-responsive, aggregation induced emission, Förster Resonance Energy Transfer, drug release
相關次數: 點閱:199  下載:2 
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • 本研究合成出具有聚集誘導螢光(AIE)性質之雙親性嵌段共聚高分子Thioketal-poly(-caprolactone)-b-poly(triethylene glycol methyl ether methacrylate -co-(1, 2, 3, 4, 5-pentaphenyl-1H-silol-1-yloxy) ethyl methacrylate)) (TKPCTAIE)以及具備多種環境響應性以及主動標靶特性之雙親性嵌段共聚高分子Thioketal-poly(-caprolactone)-b-poly(triethylene glycol methyl ether methacrylate-co-folic acid) (TKPCTFA),將兩種高分子置於水溶液中自組裝形成高分子微胞,針對其螢光特性與環境響應性進行探討。
    雙親性高分子之組成由疏水性鏈段poly(-caprolactone) (PCL)以及包含溫度響應性單體triethylene glycol methyl ether methacrylate (TEGMA)與具備酸鹼響應性與主動標靶特性之葉酸單體組成之親水性鏈段,因為在多數癌症細胞的表面都具有葉酸受體,因此在藥物載體表面修飾上葉酸作為配體後當受體與配體結合後即能夠順利進入至細胞內部,另外,因為葉酸本身具備的酸性,當其在生理環境內(pH 7.3)時,因為去質子化形成羧酸根離子使得水溶性提高,形成較為穩定之結構,反之當處於偏向酸性環境之腫瘤細胞內(pH 5.3)時,因為無法形成離子狀態導致溶解度下降,結構轉變為不穩定狀態。而親水性與疏水性鏈段之間則是以具有氧化還原響應性之縮硫酮(Thioketal)鍵結連接形成雙親性嵌段高分子TKPCTFA,另外再將螢光單體(1, 2, 3, 4, 5-pentaphenyl-1H-silol-1-yloxy) ethyl methacrylate (PPSHEMA)修飾於相似雙親性高分子之親水鏈段上,形成TKPCTAIE。
    本研究藉由混合上述兩種高分子並且期望組成之高分子混合微胞之最低臨界溫度(LCST)於中性環境下高於人體體溫但在酸性環境下低於或接近於人體體溫,同時還可以藉由活性氧類物質(ROS)將縮硫酮鍵結切斷使得微胞型態崩解,因為在腫瘤細胞中會含有較高濃度之H2O2 (100 M),而縮硫酮鍵結會與H2O2反應後段鍵形成硫醇,幫助釋放藥物以毒殺細胞。在本研究中包覆的藥物為阿黴素(Doxorubicin, DOX),而螢光單體PPSHEMA之放射光譜與DOX之吸收光譜因為有部分重疊,所以當兩者距離足夠接近時(1~10 nm)便會發生Förster Resonance Energy Transfer (FRET)效應,可以藉由此現象判斷藥物釋放程度。
    由藥物釋放的實驗結果可以證實本研究合成之高分子混合微胞在包覆藥物後於中性環境(pH 7.3)體溫(37℃)下兩天的釋放量約為15%,表示其在人體內運輸的過程中不會有大量的藥物洩漏,而隨著環境由中性變為酸性(pH 5.3),藥物釋放量明顯上升,而加入ROS(100 M H2O2)後也可以提升藥物釋放量,最後當包覆藥物之混合微胞在酸性且含有ROS環境中釋放兩天可以達到接近70%的藥物釋放量,除此之外,透過細胞毒性實驗得知此包覆藥物之混合微胞IC50約為22 g/mL。

    In this research, we synthesize two amphiphilic block copolymers, PCL-TK-b-P(TEGMA-co-PPPSHEMA) (TKPCTAIE) with aggregation induced emission (AIE) characteristic and PCL-TK-b-P(TEGMA-co-folic acid) (TKPCTFA) with multi-stimuli responsive and active targeting behaviors. Then we investigate a mixed polymeric micelle system self-assembled from these two copolymers. In this study, we focus on its fluorescent properties, environmental responsiveness, drug release, and cytotoxicity of HeLa cells of this mixed micelle.
    In the micelle system, the hydrophobic chain of the polymer is made by poly(-caprolactone) (PCL) and the hydrophilic chain is made by TEGMA and folic acid. TEGMA is a thermos-responsive monomer and folic acid is a pH-responsive and active targeting monomer. Due to the variation of pH value among endosomes (pH 5.3), lysosomes (pH 5.3), and normal tissue (pH 7.3). Besides, the hydrophobic and hydrophilic chains are connected with thioketal, which is a redox-responsive bond. Furthermore, we connected the PPSHEMA with AIE characteristic to another amphiphilic block copolymer to form TKPCTAIE.
    We controlled the lower critical solution temperature by changing the mixing ratio of TKPCTFA to TKPCTAIE. Moreover, we expect that higher reactive oxygen species (ROS) concentration (100 M H2O2) could cleave thioketal bond into acetone and thiol, and thus increasing the amount of drug release to kill tumor cells. The encapsulated drug in this research is doxorubicin (DOX). Because of the overlap of PPSHEMA fluorescent and DOX absorption spectrum, Förster Resonance Energy Transfer (FRET) would occur if PPSHEMA was closed enough to DOX. We could keep track of drug loading and drug release via FRET effect. Through the cytotoxicity test, we also prove the drug-loaded mixed micelles were the ability to kill the HeLa cells.

    摘要i Abstract iii 致謝xv 流程圖目錄xxi 表目錄xxii 公式目錄xxiii 圖目錄xxiv 第一章、 緒論(Introduction) 1 1.1 研究背景和文獻回顧(Literature review) 1 1.1.1 藥物傳遞系統(Drug Delivery System, DDS) 1 1.1.1.1 奈米藥物載體(Nano sized drug carrier) 1 1.1.1.2 藥物輸送(Drug delivery) 2 1.1.1.3 藥物釋放(Drug release) 5 1.1.2 多功能性高分子(Multifunctional polymer) 6 1.1.2.1 雙親性嵌段共聚高分子(Amphiphilic block copolymers, ABCs) 6 1.1.2.1.1 原子轉移自由基聚合(Atom transfer radical polymerization, ATRP) 6 1.1.2.1.2 環境刺激響應性(Environmental stimuli responsiveness) 6 1.1.2.1.2.1 溫度響應性(Thermo-responsive) 7 1.1.2.1.2.2 酸鹼響應性(pH-responsive) 10 1.1.2.1.2.3 氧化還原響應性(redox-responsive) 14 1.1.3 微胞性質(Properties of micelle) 18 1.1.3.1 微胞製備與藥物包覆(micelle preparation & Drug loading) 19 1.1.3.2 臨界微胞濃度(Critical micelle concentration, CMC) 19 1.1.4 螢光材料(Fluorescent materials) 20 1.1.4.1 螢光簡介(Introduction of fluorescence) 20 1.1.4.2 共振能量轉移(Förster Resonance Energy Transfer, FRET) 21 1.1.4.3 聚集誘導螢光性質(Aggregation-induced Emission, AIE) 23 1.2 研究動機與目的(Motivation)26 第二章、 實驗(Experiments)28 2.1 實驗藥品(Chemicals) 28 2.2 實驗方法(Experimrnts) 30 2.2.1 單體合成(Synthesis of monomer) 30 2.2.1.1 起始劑合成30 2.2.1.1.1 2,2’- (propane-2,2-diylbis(sulfanediyl))diacetic acid (TKCOOH) 30 2.2.1.1.2 2,2'-(propane-2,2-diylbis(sulfanediyl))bis(ethan-1-ol) (TKOH) 30 2.2.1.1.3 2-((2-((2-hydroxyethyl)thio)propan-2-yl)thio)ethyl 2-bromo-2-methylpropanoate (OH-TK-iBuBr) 31 2.2.1.2 N-hydroxysuccinimide methacrylate (NSMA) 32 2.2.1.3 (1, 2, 3, 4, 5-pentaphenyl-1H-silol-1-yloxy) ethyl methacrylate (PPSHEMA) 33 2.2.2 高分子聚合(Polymerization) 34 2.2.2.1 Thioketal-poly(-caprolactone) (TKPCL) 34 2.2.2.2 Thioketal-poly(-caprolactone)-b-poly(triethylene glycol methyl ether methacrylate -co- N-hydroxysuccinimide methacrylate) (TKPCTN) 35 2.2.2.3 Thioketal-poly(-caprolactone)-b-poly(triethylene glycol methyl ether methacrylate-co-folic acid) (TKPCTFA) 37 2.2.2.4 Thioketal-poly(-caprolactone)-b-poly(triethylene glycol methyl ether methacrylate -co-(1, 2, 3, 4, 5-pentaphenyl-1H-silol-1-yloxy) ethyl methacrylate)) (TKPCTAIE) 39 2.2.3 微胞製備(Preparation of micelles) 41 2.2.4 最低臨界溫度(Lower Critical Solution Temperature, LCST) 41 2.2.5 臨界微胞濃度(Critical Micelle Concentration, CMC) 41 2.2.6 藥物包覆與釋放(Drug loading and drug release) 42 2.2.6.1 藥物包覆(Drug loading) 42 2.2.6.2 藥物釋放(Drug release) 43 2.2.7 細胞毒性測試(Cell culture and cytotoxicity asssays) 44 2.2.7.1 細胞培養(Cell culture) 44 2.2.7.2 細胞毒性測試(In vitro cytotoxicity assay):PrestoBlueTM 44 2.3 儀器鑑定(Characterization) 46 2.3.1 Nuclear Magnetic Resonance (NMR) 46 2.3.2 Ultraviolet-visible spectroscopy (UV-vis) 46 2.3.3 Gel Permeation Chromatography (GPC) 47 2.3.4 Dynamic Light Scattering (DLS) 47 2.3.5 Photoluminescence Spectroscopy (PL) 48 2.3.6 Enzyme-Linked Immunosorbent Assay (ELISA) Reader 48 第三章、 結果與討論(Results and discusion) 49 3.1 合成與鑑定(Synthesis and characterization) 49 3.1.1 起始劑 HO-TK-iBuBr 合成50 3.1.1.1 TKCOOH 合成50 3.1.1.2 TKOH合成51 3.1.1.3 HO-TK-iBuBr合成52 3.1.2 NSMA 單體合成53 3.1.3 PPSHEMA 單體合成54 3.1.4 TKPCL 高分子聚合55 3.1.5 TKPCTFA 雙親性嵌段高分子聚合56 3.1.6 TKPCTAIE 雙親性嵌段高分子聚合59 3.2 混合微胞的製備與性質鑑定(Preparation and characterization of mixed micelles) 61 3.2.1 溫度響應性(Thermo-responsive behaviors) 61 3.2.2 臨界微胞濃度(Test of CMC) 66 3.2.3 微胞粒徑分佈(Size distribution of micelles) 67 3.2.4 氧化還原響應性(Redox-responsive behaviors) 68 3.2.5 混合微胞之螢光特性(Fluorescent properties of mixed micelles) 69 3.3 混合微胞藥物釋放檢測(In vitro drug release) 70 3.3.1 混合微胞之藥物包覆比例(Drug loading content and encapsulation efficiency, LC and EE) 70 3.3.2 混合微胞之藥物釋放(In vitro drug release of mixed micelles) 71 3.3.3 混合微胞之藥物釋放(In vitro drug release of mixed micelles) 72 3.4 細胞毒性定量分析(Cytotoxocity assays) 74 第四章、 結論與未來工作(Conclusion and future works) 76 第五章、 參考文獻(References) 78

    1. Huang, L., et al., Novel nano-drug delivery system for natural products and their application. Pharmacol Res, 2024. 201: p. 107100.
    2. Jadhav, V., et al., Current advancements in functional nanomaterials for drug delivery systems. Nano-Structures & Nano-Objects, 2024. 38.
    3. Peng, C., Y. Huang, and J. Zheng, Renal clearable nanocarriers: Overcoming the physiological barriers for precise drug delivery and clearance. J Control Release, 2020. 322: p. 64-80.
    4. Sun, R., et al., The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives. Adv Drug Deliv Rev, 2022. 191: p. 114614.
    5. Kandula, S., et al., Trends in smart drug delivery systems for targeting cancer cells. Materials Science and Engineering: B, 2023. 297.
    6. Ghalehkhondabi, V., A. Fazlali, and M. Soleymani, Folic acid-conjugated pH-responsive poly(methacrylic acid) nanospheres for targeted delivery of anticancer drugs to breast cancer cells. Journal of Molecular Liquids, 2022. 348.
    7. Patel, D., et al., Exploring the potential of P-glycoprotein inhibitors in the targeted delivery of anti-cancer drugs: A comprehensive review. Eur J Pharm Biopharm, 2024. 198: p. 114267.
    8. Sun, T. and C. Jiang, Stimuli-responsive drug delivery systems triggered by intracellular or subcellular microenvironments. Adv Drug Deliv Rev, 2023. 196: p. 114773.
    9. Xu, X., et al., ROS-Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy. Adv Mater, 2017. 29(33).
    10. Siegwart, D.J., J.K. Oh, and K. Matyjaszewski, ATRP in the design of functional materials for biomedical applications. Prog Polym Sci, 2012. 37(1): p. 18-37.
    11. Wang, J.-S. and K. Matyjaszewski, Controlled/"living" radical polymerization. atom transfer radical polymerization in the presence of transition-metal complexes. Journal of the American Chemical Society, 1995. 117(20): p. 5614-5615.
    12. Król, P. and P. Chmielarz, Recent advances in ATRP methods in relation to the synthesis of copolymer coating materials. Progress in Organic Coatings, 2014. 77(5): p. 913-948.
    13. Najjari, Z., F. Sadri, and J. Varshosaz, Smart stimuli-responsive drug delivery systems in spotlight of COVID-19. Asian J Pharm Sci, 2023. 18(6): p. 100873.
    14. Manfredini, N., et al., Thermo-responsive polymers as surface active compounds: A review. European Polymer Journal, 2023. 198.
    15. Sponchioni, M., U. Capasso Palmiero, and D. Moscatelli, Thermo-responsive polymers: Applications of smart materials in drug delivery and tissue engineering. Mater Sci Eng C Mater Biol Appl, 2019. 102: p. 589-605.
    16. Bordat, A., et al., Thermoresponsive polymer nanocarriers for biomedical applications. Adv Drug Deliv Rev, 2019. 138: p. 167-192.
    17. Convertine, A.J., et al., Direct Synthesis of Thermally Responsive DMA/NIPAM Diblock and DMA/NIPAM/DMA Triblock Copolymers via Aqueous, Room Temperature RAFT Polymerization. Macromolecules, 2006. 39(5): p. 1724-1730.
    18. Ishizone, T., et al., Anionic Polymerizations of Oligo(ethylene glycol) Alkyl Ether Methacrylates: Effect of Side Chain Length and ω-Alkyl Group of Side Chain on Cloud Point in Water. Macromolecules, 2008. 41(8): p. 2963-2967.
    19. Ofridam, F., et al., pH‐sensitive polymers: Classification and some fine potential applications. Polymers for Advanced Technologies, 2021. 32(4): p. 1455-1484.
    20. Weber, C., R. Hoogenboom, and U.S. Schubert, Temperature responsive bio-compatible polymers based on poly(ethylene oxide) and poly(2-oxazoline)s. Progress in Polymer Science, 2012. 37(5): p. 686-714.
    21. Geven, M., et al., Sulfur-based oxidation-responsive polymers. Chemistry, (chemically selective) responsiveness and biomedical applications. European Polymer Journal, 2021. 149.
    22. Liu, B. and S. Thayumanavan, Mechanistic Investigation on Oxidative Degradation of ROS-Responsive Thioacetal/Thioketal Moieties and Their Implications. Cell Reports Physical Science, 2020. 1(12).
    23. Xu, L., et al., Polymeric nanoparticles responsive to intracellular ROS for anticancer drug delivery. Colloids Surf B Biointerfaces, 2019. 181: p. 252-260.
    24. Kesharwani, S.S., et al., Multifunctional approaches utilizing polymeric micelles to circumvent multidrug resistant tumors. Colloids Surf B Biointerfaces, 2019. 173: p. 581-590.
    25. Farhoudi, L., et al., Polymeric micelles paving the Way: Recent breakthroughs in camptothecin delivery for enhanced chemotherapy. Int J Pharm, 2024. 659: p. 124292.
    26. Chen, D., et al., Non-noble-metal-based organic emitters for OLED applications. Materials Science and Engineering: R: Reports, 2020. 142.
    27. Shen, Y., et al., FRET-based innovative assays for precise detection of the residual heavy metals in food and agriculture-related matrices. Coordination Chemistry Reviews, 2022. 469.
    28. Chen, Y., et al., Visualization and correlation of drug release of risperidone/clozapine microspheres in vitro and in vivo based on FRET mechanism. Int J Pharm, 2024. 653: p. 123885.
    29. Zalmi, G.A., et al., Recent Advances in Aggregation-Induced Emission Active Materials for Sensing of Biologically Important Molecules and Drug Delivery System. Molecules, 2021. 27(1).
    30. Liu, Y., et al., An efficient FRET based theranostic nanoprobe for hyaluronidase detection and cancer therapy in vitro. Sensors and Actuators B: Chemical, 2021. 344.
    31. Li, J., et al., Organic Semiconducting Pro-nanostimulants for Near-Infrared Photoactivatable Cancer Immunotherapy. Angew Chem Int Ed Engl, 2019. 58(36): p. 12680-12687.
    32. Chu, B., et al., ROS‐Responsive Camptothecin Prodrug Nanoparticles for On‐Demand Drug Release and Combination of Chemotherapy and Photodynamic Therapy. Advanced Functional Materials, 2020. 30(52).
    33. Batz, H.G., G. Franzmann, and H. Ringsdorf, Model reactions for synthesis of pharmacologically active polymers by way of monomeric and polymeric reactive esters. Angew Chem Int Ed Engl, 1972. 11(12): p. 1103-4.
    34. Chen, J.I. and W.C. Wu, Fluorescent polymeric micelles with aggregation-induced emission properties for monitoring the encapsulation of doxorubicin. Macromol Biosci, 2013. 13(5): p. 623-32.

    下載圖示
    2026-08-31公開
    QR CODE